Eintrag weiter verarbeiten
Monitoring Patients on Metformin: Recent Changes and Rationales
Gespeichert in:
| Zeitschriftentitel: | Journal of Pharmacy Technology |
|---|---|
| Personen und Körperschaften: | , |
| In: | Journal of Pharmacy Technology, 34, 2018, 1, S. 28-36 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
SAGE Publications
|
| Schlagwörter: |
| author_facet |
Wooley, Andrea C. Kerr, Jessica L. Wooley, Andrea C. Kerr, Jessica L. |
|---|---|
| author |
Wooley, Andrea C. Kerr, Jessica L. |
| spellingShingle |
Wooley, Andrea C. Kerr, Jessica L. Journal of Pharmacy Technology Monitoring Patients on Metformin: Recent Changes and Rationales Pharmaceutical Science |
| author_sort |
wooley, andrea c. |
| spelling |
Wooley, Andrea C. Kerr, Jessica L. 8755-1225 1549-4810 SAGE Publications Pharmaceutical Science http://dx.doi.org/10.1177/8755122517747295 <jats:p> Objective: The Food and Drug Administration recently updated metformin prescribing recommendations for patients with diabetes and renal disease. The American Diabetes Association as well as the American Association of Clinical Endocrinologists and American Clinical Endocrinologists also recommend periodic monitoring of vitamin B<jats:sub>12</jats:sub> levels for patients using metformin. A review of the literature was conducted to assess data to evaluate the recent updates to metformin usage and provide rationales for these recommendations. Data Sources: PubMed MESH terms “Diabetes Mellitus, Type 2” and “Renal Insufficiency, Chronic” and “Metformin” were searched with an English limitation from 1990 to May 2017. A MEDLINE search was conducted using the terms “metformin” and “renal disease” from 1990 to May 2017. A PubMed search was conducted using the MESH terms “vitamin b12 deficiency” and “metformin” from 1970 to May 2017. A MEDLINE search was conducted using terms “metformin” and “vitamin B12 deficiency” with an English limitation from 1970 to May 2017. Study Selection and Data Extraction: Retrospective and prospective clinical trials, meta-analyses, and systematic reviews were considered for inclusion. Citations from identified articles were also reviewed for inclusion. Data Synthesis: The incidence of metformin-associated lactic acidosis is minimal. Data indicate metformin-treated patients with an estimated glomerular filtration rate above 30 mL/min/1.73 m<jats:sup>2</jats:sup> have a reduction in mortality. Additionally, data suggest metformin may lead to vitamin B<jats:sub>12</jats:sub> deficiency. Conclusion: Data support recommendations for metformin use in patients with diabetes and renal insufficiency with an estimated glomerular filtration rate above 30 mL/min/1.73 m<jats:sup>2</jats:sup>. Data also suggest that baseline and periodic testing of vitamin B<jats:sub>12</jats:sub> levels are warranted and supported by clinical guidelines due to the risk of vitamin B<jats:sub>12</jats:sub> deficiency in metformin-treated patients. </jats:p> Monitoring Patients on Metformin: Recent Changes and Rationales Journal of Pharmacy Technology |
| doi_str_mv |
10.1177/8755122517747295 |
| facet_avail |
Online Free |
| finc_class_facet |
Chemie und Pharmazie |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny84NzU1MTIyNTE3NzQ3Mjk1 |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny84NzU1MTIyNTE3NzQ3Mjk1 |
| institution |
DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Rs1 DE-Pl11 DE-105 DE-14 DE-Ch1 |
| imprint |
SAGE Publications, 2018 |
| imprint_str_mv |
SAGE Publications, 2018 |
| issn |
8755-1225 1549-4810 |
| issn_str_mv |
8755-1225 1549-4810 |
| language |
English |
| mega_collection |
SAGE Publications (CrossRef) |
| match_str |
wooley2018monitoringpatientsonmetforminrecentchangesandrationales |
| publishDateSort |
2018 |
| publisher |
SAGE Publications |
| recordtype |
ai |
| record_format |
ai |
| series |
Journal of Pharmacy Technology |
| source_id |
49 |
| title |
Monitoring Patients on Metformin: Recent Changes and Rationales |
| title_unstemmed |
Monitoring Patients on Metformin: Recent Changes and Rationales |
| title_full |
Monitoring Patients on Metformin: Recent Changes and Rationales |
| title_fullStr |
Monitoring Patients on Metformin: Recent Changes and Rationales |
| title_full_unstemmed |
Monitoring Patients on Metformin: Recent Changes and Rationales |
| title_short |
Monitoring Patients on Metformin: Recent Changes and Rationales |
| title_sort |
monitoring patients on metformin: recent changes and rationales |
| topic |
Pharmaceutical Science |
| url |
http://dx.doi.org/10.1177/8755122517747295 |
| publishDate |
2018 |
| physical |
28-36 |
| description |
<jats:p> Objective: The Food and Drug Administration recently updated metformin prescribing recommendations for patients with diabetes and renal disease. The American Diabetes Association as well as the American Association of Clinical Endocrinologists and American Clinical Endocrinologists also recommend periodic monitoring of vitamin B<jats:sub>12</jats:sub> levels for patients using metformin. A review of the literature was conducted to assess data to evaluate the recent updates to metformin usage and provide rationales for these recommendations. Data Sources: PubMed MESH terms “Diabetes Mellitus, Type 2” and “Renal Insufficiency, Chronic” and “Metformin” were searched with an English limitation from 1990 to May 2017. A MEDLINE search was conducted using the terms “metformin” and “renal disease” from 1990 to May 2017. A PubMed search was conducted using the MESH terms “vitamin b12 deficiency” and “metformin” from 1970 to May 2017. A MEDLINE search was conducted using terms “metformin” and “vitamin B12 deficiency” with an English limitation from 1970 to May 2017. Study Selection and Data Extraction: Retrospective and prospective clinical trials, meta-analyses, and systematic reviews were considered for inclusion. Citations from identified articles were also reviewed for inclusion. Data Synthesis: The incidence of metformin-associated lactic acidosis is minimal. Data indicate metformin-treated patients with an estimated glomerular filtration rate above 30 mL/min/1.73 m<jats:sup>2</jats:sup> have a reduction in mortality. Additionally, data suggest metformin may lead to vitamin B<jats:sub>12</jats:sub> deficiency. Conclusion: Data support recommendations for metformin use in patients with diabetes and renal insufficiency with an estimated glomerular filtration rate above 30 mL/min/1.73 m<jats:sup>2</jats:sup>. Data also suggest that baseline and periodic testing of vitamin B<jats:sub>12</jats:sub> levels are warranted and supported by clinical guidelines due to the risk of vitamin B<jats:sub>12</jats:sub> deficiency in metformin-treated patients. </jats:p> |
| container_issue |
1 |
| container_start_page |
28 |
| container_title |
Journal of Pharmacy Technology |
| container_volume |
34 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792336822445015048 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T15:06:30.62Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Monitoring+Patients+on+Metformin%3A+Recent+Changes+and+Rationales&rft.date=2018-02-01&genre=article&issn=1549-4810&volume=34&issue=1&spage=28&epage=36&pages=28-36&jtitle=Journal+of+Pharmacy+Technology&atitle=Monitoring+Patients+on+Metformin%3A+Recent+Changes+and+Rationales&aulast=Kerr&aufirst=Jessica+L.&rft_id=info%3Adoi%2F10.1177%2F8755122517747295&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792336822445015048 |
| author | Wooley, Andrea C., Kerr, Jessica L. |
| author_facet | Wooley, Andrea C., Kerr, Jessica L., Wooley, Andrea C., Kerr, Jessica L. |
| author_sort | wooley, andrea c. |
| container_issue | 1 |
| container_start_page | 28 |
| container_title | Journal of Pharmacy Technology |
| container_volume | 34 |
| description | <jats:p> Objective: The Food and Drug Administration recently updated metformin prescribing recommendations for patients with diabetes and renal disease. The American Diabetes Association as well as the American Association of Clinical Endocrinologists and American Clinical Endocrinologists also recommend periodic monitoring of vitamin B<jats:sub>12</jats:sub> levels for patients using metformin. A review of the literature was conducted to assess data to evaluate the recent updates to metformin usage and provide rationales for these recommendations. Data Sources: PubMed MESH terms “Diabetes Mellitus, Type 2” and “Renal Insufficiency, Chronic” and “Metformin” were searched with an English limitation from 1990 to May 2017. A MEDLINE search was conducted using the terms “metformin” and “renal disease” from 1990 to May 2017. A PubMed search was conducted using the MESH terms “vitamin b12 deficiency” and “metformin” from 1970 to May 2017. A MEDLINE search was conducted using terms “metformin” and “vitamin B12 deficiency” with an English limitation from 1970 to May 2017. Study Selection and Data Extraction: Retrospective and prospective clinical trials, meta-analyses, and systematic reviews were considered for inclusion. Citations from identified articles were also reviewed for inclusion. Data Synthesis: The incidence of metformin-associated lactic acidosis is minimal. Data indicate metformin-treated patients with an estimated glomerular filtration rate above 30 mL/min/1.73 m<jats:sup>2</jats:sup> have a reduction in mortality. Additionally, data suggest metformin may lead to vitamin B<jats:sub>12</jats:sub> deficiency. Conclusion: Data support recommendations for metformin use in patients with diabetes and renal insufficiency with an estimated glomerular filtration rate above 30 mL/min/1.73 m<jats:sup>2</jats:sup>. Data also suggest that baseline and periodic testing of vitamin B<jats:sub>12</jats:sub> levels are warranted and supported by clinical guidelines due to the risk of vitamin B<jats:sub>12</jats:sub> deficiency in metformin-treated patients. </jats:p> |
| doi_str_mv | 10.1177/8755122517747295 |
| facet_avail | Online, Free |
| finc_class_facet | Chemie und Pharmazie |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny84NzU1MTIyNTE3NzQ3Mjk1 |
| imprint | SAGE Publications, 2018 |
| imprint_str_mv | SAGE Publications, 2018 |
| institution | DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Rs1, DE-Pl11, DE-105, DE-14, DE-Ch1 |
| issn | 8755-1225, 1549-4810 |
| issn_str_mv | 8755-1225, 1549-4810 |
| language | English |
| last_indexed | 2024-03-01T15:06:30.62Z |
| match_str | wooley2018monitoringpatientsonmetforminrecentchangesandrationales |
| mega_collection | SAGE Publications (CrossRef) |
| physical | 28-36 |
| publishDate | 2018 |
| publishDateSort | 2018 |
| publisher | SAGE Publications |
| record_format | ai |
| recordtype | ai |
| series | Journal of Pharmacy Technology |
| source_id | 49 |
| spelling | Wooley, Andrea C. Kerr, Jessica L. 8755-1225 1549-4810 SAGE Publications Pharmaceutical Science http://dx.doi.org/10.1177/8755122517747295 <jats:p> Objective: The Food and Drug Administration recently updated metformin prescribing recommendations for patients with diabetes and renal disease. The American Diabetes Association as well as the American Association of Clinical Endocrinologists and American Clinical Endocrinologists also recommend periodic monitoring of vitamin B<jats:sub>12</jats:sub> levels for patients using metformin. A review of the literature was conducted to assess data to evaluate the recent updates to metformin usage and provide rationales for these recommendations. Data Sources: PubMed MESH terms “Diabetes Mellitus, Type 2” and “Renal Insufficiency, Chronic” and “Metformin” were searched with an English limitation from 1990 to May 2017. A MEDLINE search was conducted using the terms “metformin” and “renal disease” from 1990 to May 2017. A PubMed search was conducted using the MESH terms “vitamin b12 deficiency” and “metformin” from 1970 to May 2017. A MEDLINE search was conducted using terms “metformin” and “vitamin B12 deficiency” with an English limitation from 1970 to May 2017. Study Selection and Data Extraction: Retrospective and prospective clinical trials, meta-analyses, and systematic reviews were considered for inclusion. Citations from identified articles were also reviewed for inclusion. Data Synthesis: The incidence of metformin-associated lactic acidosis is minimal. Data indicate metformin-treated patients with an estimated glomerular filtration rate above 30 mL/min/1.73 m<jats:sup>2</jats:sup> have a reduction in mortality. Additionally, data suggest metformin may lead to vitamin B<jats:sub>12</jats:sub> deficiency. Conclusion: Data support recommendations for metformin use in patients with diabetes and renal insufficiency with an estimated glomerular filtration rate above 30 mL/min/1.73 m<jats:sup>2</jats:sup>. Data also suggest that baseline and periodic testing of vitamin B<jats:sub>12</jats:sub> levels are warranted and supported by clinical guidelines due to the risk of vitamin B<jats:sub>12</jats:sub> deficiency in metformin-treated patients. </jats:p> Monitoring Patients on Metformin: Recent Changes and Rationales Journal of Pharmacy Technology |
| spellingShingle | Wooley, Andrea C., Kerr, Jessica L., Journal of Pharmacy Technology, Monitoring Patients on Metformin: Recent Changes and Rationales, Pharmaceutical Science |
| title | Monitoring Patients on Metformin: Recent Changes and Rationales |
| title_full | Monitoring Patients on Metformin: Recent Changes and Rationales |
| title_fullStr | Monitoring Patients on Metformin: Recent Changes and Rationales |
| title_full_unstemmed | Monitoring Patients on Metformin: Recent Changes and Rationales |
| title_short | Monitoring Patients on Metformin: Recent Changes and Rationales |
| title_sort | monitoring patients on metformin: recent changes and rationales |
| title_unstemmed | Monitoring Patients on Metformin: Recent Changes and Rationales |
| topic | Pharmaceutical Science |
| url | http://dx.doi.org/10.1177/8755122517747295 |